ATRIAL FIBRILLATION is the characteristic arrhythmia of the advanced stages of mitral stenosis, being present in 40 per cent of such cases. Paradoxically, mitral valve surgery, which relieves the obstruction and reduces the hemodynamic overload of the left atrium, frequently precipitates either transient or permanent atrial fibrillation. The reported incidence of this disorder after mitral operation ranges from 24 to 47 per cent. '-6 In the patient with normal sinus rhythm undergoing mitral valve surgery atrial fibrillation thus constitutes the most common operative complication.
Physiologic studies clearly indicate that atrial fibrillation compromises cardiac function. Restoration of normal sinus rhythm has been shown to increase the cardiac output at rest and especially after exercise.7-10 It has been observed that patients with atrial fibrillation have generally lower cardiac outputs, higher pulmonary vascular resistance, and higher left atrial and pulmonary arterial pressures than do patients with mitral stenosis in sinus rhythm."1 12 The ventricular rate in atrial fibrillation is unstable and prone to acceleration to more than 100 per minute. In some fully digitalized patients ventricular rates as high as 170 have been recorded following moderate exercise or administration of atropine.13 Occasionally in the presence of this arrhythmia congestive failure cannot be controlled, even though the heart rate is slow, until normal sinus rhythm has been restored. It 15 Of greater clinical importance is the fact that this arrhythmia bears an etiologic relationship to cerebral and peripheral arterial embolization. Thus, the prevention of atrial fibrillation and its prompt conversion to a normal mechanism are sound clinical practice.
The present study had as its primary purpose the assessment of the effectiveness of quinidine in the prevention of postoperative atrial fibrillation. In addition, observations were made on the safety of using quinidine prophylactically during and following a cardiac operation and on the background factors that might predispose to this arrhythmia.
Materials and Methods
The investigation consisted of two phases, a retrospective and a prospective study.
Retrospective Study
The retrospective study consisted In the retrospective series quinidine prophylaxis had been applied empirically when it was observed that there was a very high incidence of postoperative atrial fibrillation following mitral valvuloplasty. Thirty-eight of the group-III patients, most of them from the first part of the series who were among the earliest operated on for mitral stenosis, received no quinidine and served as controls. The remaining 188 group-III patients received this medication, beginning within 6 hours of the end of operation in the majority and administered in doses of 0.8 to 1.2 Gm. per day.
In group IV 22 of the 29 patients received quinidine.
Prospective Study
In order to determine the effectiveness of quinidine prophylaxis under more controlled conditions a prospective study was also undertaken. For The influence of various clinical factors on the incidence of postoperative atrial fibrillation was also examined in this combined series. Table 2 presents the results of this analysis. In the control patients, receiving no quinidine, arthralgia as an indicator of rheumatic activity, the presence of mitral insufficiency and age beyond 35 years did not significantly alter the incidence of this arrhythmia. In these patients, however, the occurrence of prior atrial fibrillation, episodes of palpitation, and male sex resulted in approximately a two-fold increase in percentage of fibrillation. These differences, however, were just short of significance at the 5 per cent confidence level by Chi-square test.
These factors, namely, prior atrial arrhythmia, palpitation, and male sex were associated with an increased incidence of postoperative atrial fibrillation even when the patients were receiving prophylactic quinidine. Of the men who received quinidine, those above 35 years of age had a significantly greater incidence of this arrhythmia. It is noteworthy that the same factors (prior arrhythmia and male sex) caused a distinct increase in incidence of postoperative fibrillation in both control and treated groups. The failure to achieve the 5 per cent confidence level in the controls may be due to the small number of observations available for analysis.
Unlike atrial fibrillation occurring in the course of untreated mitral stenosis, the postoperative arrhythmia frequently reverted spontaneously without specific treatment other than rate control with increased doses of digitalis. Thus in group III, of 82 patients who fibrillated postoperatively, 27 or 33 per cent reverted spontaneously to normal sinus rhythm. In group IV 5 of 22 or 23 per cent reverted. There was no significant difference between the rates of spontaneous reversion whether or not quinidine prophylaxis had been employed.
In the majority of those patients who remained in atrial fibrillation even though the ventricular rate was controlled with digitalis, an attempt was made to revert the arrhythmia with quinidine on about the tenth postoperative day by the method of Sokolow. The present study conclusively demonstrates the value of quinidine in preventing atrial fibrillation after mitral valvuloplasty. From these results one would predict that in 100 patients of group III with normal sinus rhythm undergoing mitral valvuloplasty the use of quinidine will reduce the number who fibrillate postoperatively from 42 to 22. Eight of the 22 who thus fibrillate will revert spontaneously to normal sinus rhythm when their rate is controlled with additional doses of digitalis. Normal rhythm can be restored in 12 of the remaining 14 patients by the use of quinidine in increasing doses after the tenth postoperative day. Two patients of the original 100 will remain permanently in atrial fibrillation. When, however, prophylactic quinidine is not employed seven patients will remain in this disordered rhythm ( In our series with total daily doses of 0.8 to 1.2 Gm. per day there were no deaths and no quinidine-induced arrhythmias. Quinidine had to be discontinued in only two patients of the 82 in the prospective study at 4 and 9 days postoperatively, respectively, because of gastrointestinal intolerance.
Conclusions
A study has been conducted to determine the effectiveness of quinidine prophylaxis in reducing the incidence of atrial fibrillation in patients with normal sinus rhythm undergoing operation for mitral stenosis. In both a retrospective study of 226 group-III patients and in a more rigidly controlled prospective study of 41 pairs of patients a statistically significant reduction in the incidence of this arrhythmia was observed (from 42 to 22 per cent). Moderate dosages (0.8 to 1.2 Gm. per day) were effective.
A history of palpitation or prior episodes of atrial fibrillation and male sex appeared to be related to the development of postoperative atrial fibrillation. Associated mitral insufficiency, Aschoff bodies in the atrial appendage, and recent history of arthralgia did not appear to increase significantly the incidence of this arrhythmia.
If prophylactic quinidine is employed and reversion is attempted after the tenth postoperative day in those patients who nonetheless developed atrial fibrillation, only 1.5 per cent of patients in normal sinus rhythm operated on for mitral stenosis will be discharged from the hospital with an irregular rhythm.
